TY  - JOUR

T1  - Dupilumab safety and efficacy up to 1 Year in children aged 6 months to 5 years with atopic dermatitis: results from a phase 3 open-label extension study

JO  - American Journal of Clinical Dermatology

UR  - https://eprints.whiterose.ac.uk/id/eprint/213392

PY  - 2024/05/14

AU  - Paller AS

AU  - Siegfried EC

AU  - Simpson EL

AU  - Cork MJ

AU  - Sidbury R

AU  - Chen IH

AU  - Khokhar FA

AU  - Xiao J

AU  - Dubost-Brama A

AU  - Bansal A

ED  - 

DO  - DOI: 10.1007/s40257-024-00859-y

PB  - Springer Science and Business Media LLC

VL  - 25

IS  - 4

SP  - 655

EP  - 668

Y2  - 2025/04/06

ER  -